Market Entry Diagnostics

Market Entry Diagnostics

A focused 2-4 week engagement to assess your innovation, identify the optimal market, and build a clear entry strategy across Europe & Asia Pacific

A focused 2-4 week engagement to assess your innovation, identify the optimal market, and build a clear entry strategy across Europe & Asia Pacific

Format

Remote or hybrid — Europe & Asia Pacific

Duration

2-4 weeks

Best for

Preventative medicine, longevity science and regenerative therapies preparing to expand internationally

Price

On request

You don't need another market report. You need to know exactly where to go first — and why.

Expanding into a new market is one of the highest-stakes decisions a healthspan company makes. The wrong market at the wrong moment can cost years of momentum, burn relationships, and drain resources that could have built something real elsewhere.

Market Entry Diagnostics exists to prevent that.

In a focused 2-4 week engagement, we assess your innovation against the specific realities of your target markets — regulatory architecture, cultural adoption dynamics, healthcare infrastructure, reimbursement logic, and the unwritten rules that determine whether an innovation gets trusted or ignored.

We don't just tell you where the opportunity is. We tell you whether you're ready for it — and exactly what needs to happen before you are.

What we deliver

  • A clear market selection rationale — the right first market for your specific innovation

  • A regulatory and cultural landscape assessment for each target market

  • An honest gap analysis — commercial, scientific, and operational

  • A prioritised action plan with a clear entry sequence

  • A written market brief your whole team can align around

This engagement is right for you if

  • You have a proven innovation ready for international expansion

  • You are considering Europe or Asia Pacific as target markets

  • You want strategic clarity before committing to full execution

Market Entry Diagnostics is the natural first step. For companies ready to move from strategy to execution, this leads directly into our Hands-On Advisory.

You don't need another market report. You need to know exactly where to go first — and why.

Expanding into a new market is one of the highest-stakes decisions a healthspan company makes. The wrong market at the wrong moment can cost years of momentum, burn relationships, and drain resources that could have built something real elsewhere.

Market Entry Diagnostics exists to prevent that.

In a focused 2-4 week engagement, we assess your innovation against the specific realities of your target markets — regulatory architecture, cultural adoption dynamics, healthcare infrastructure, reimbursement logic, and the unwritten rules that determine whether an innovation gets trusted or ignored.

We don't just tell you where the opportunity is. We tell you whether you're ready for it — and exactly what needs to happen before you are.

What we deliver

  • A clear market selection rationale — the right first market for your specific innovation

  • A regulatory and cultural landscape assessment for each target market

  • An honest gap analysis — commercial, scientific, and operational

  • A prioritised action plan with a clear entry sequence

  • A written market brief your whole team can align around

This engagement is right for you if

  • You have a proven innovation ready for international expansion

  • You are considering Europe or Asia Pacific as target markets

  • You want strategic clarity before committing to full execution

Market Entry Diagnostics is the natural first step. For companies ready to move from strategy to execution, this leads directly into our Hands-On Advisory.